Aptorum Group Ltd - APM Net earnings per one share for the last twelve months

Aptorum Group Limited (APM) - corporate logo

The Aptorum Group Limited (APM) ecosystem develops treatments for infections and orphan pathologies utilizing the Smart-ACT platform. Development efficiency is sustained by outsourcing tests to external contractors under strict cost audits. The annual shift in EPS TTM visualizes the result of this synergy, with the metric holding at -1985.00. Business scalability is ensured by selling molecule rights to industry behemoths, thereby eliminating capital expenditures for manufacturing plants.

Aptorum Group Limited - APM Net earnings per share (EPS TTM) (period 02/11/2024 - 07/20/2026)

Financial and market metric breakdowns for Aptorum (APM)

- current price and projected stock value:
Price Performance Chart Aptorum Group Limited|APM - Analyst Consensus Forecast
- issuer market value details:
Market Value Aptorum Group Ltd|APM - Total Company Value
- company book value details:
Accounting Value of a Share Aptorum Group|APM - Book Capitalization|Market Capitalization to Book Value Ratio aptorumgroup.com|APM - Aggregate Company Assets
- debt and liquidity data:
Aggregate Debt to Equity Aptorum Group Limited|APM - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Aptorum Group Limited|APM - Company Debts|Debts to Book Value Aptorum Group Ltd|APM - Company Long-Term Debt|Company Short-Term Loans and Borrowings Aptorum Group|Quick Ratio aptorumgroup.com
- financial results and valuation multiples details:
APM - Company Net Income|Future Profit Aptorum Group Limited|APM - Price to Earnings Ratio|Future Price to Earnings Multiple Aptorum Group Limited|APM - PEG Multiple|Enterprise Value to EBITDA Multiple Aptorum Group Ltd|APM - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Aptorum Group|APM - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months aptorumgroup.com|APM - Net earnings per share growth this year|Earnings growth forecast for next year Aptorum Group Limited
- sales and revenue indicators:
APM - Company Revenue|Company Expected Revenue Aptorum Group Limited|APM - Market Cap to Revenue|Forward Price to Sales Aptorum Group Ltd
Initial company analysis:APM, Aptorum Group
Brand item of Aptorum Group Ltd

Aptorum Group Limited simplifies the balance between operating expenses and return on equity through the outsourcing of clinical trials and a lean workforce. By analyzing the EPS growth rate over the last 12 months YoY, an investor can track the net profit per share, allowing for an assessment of the business model's resilience and the risk of multiple compression during a shift in the market cycle.

Competitor analysis

Earnings per share for the trailing year HLN (haleon.com)|KVUE: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Verona Pharma PLC (VRNA)|Earnings per share for the last twelve months Jyong Biotech Corp|LGND: Earnings per share for the trailing year|Net earnings per share (EPS TTM) AMRX|Net earnings per share (EPS TTM) perrigo.com (PRGO)|Earnings per share for the last twelve months Alvotech SA ALVO|LQDA (Liquidia Corp) - Earnings per one share for the last 12 months|GLPG: Net earnings per share for the last 12 months|ANI Pharmaceuticals Corp - Earnings per share for the last four quarters|MannKind Corporation (MNKD) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months amphastar.com (AMPH)|Earnings per share for the last twelve months Pacira BioSciences, Inc.|SPRY: Earnings per share for the trailing year|Net earnings per share for the last 12 months TBPH (Theravance)|Net earnings per share (EPS TTM) Aquestive Corp (AQST)|Earnings per share for the last twelve months scPharmaceuticals SCPH|TECX - Net earnings per share for the last 12 months|TNXP: Net earnings per share for the last 12 months|Earnings per share for the trailing year SXTC (China SXT Pharmaceuticals)|EPRX: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year BioHarvest Sciences Inc BHST|Earnings per share for the last twelve months eXoZymes Inc|ORMP: Earnings per share for the trailing year|Earnings per share for the last twelve months Entera Bio Ltd. (ENTX)|HYFT - Net earnings per one share for the last twelve months|ABVC BioPharma Inc - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Cumberland Corp CPIX|QNTM - Earnings per share for the last twelve months|Earnings per one share for the last 12 months FGEN|TELO (Telomir Pharmaceuticals, Inc.) - Net earnings per share for the last 12 months|Rani Therapeutics Holdings, Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Synergy CHC Corp.|Earnings per share for the last twelve months RLYB|Net earnings per share (EPS TTM) LEXX|Net earnings per share for the last four quarters pulmatrix.com|Earnings per share for the last twelve months Pheton Holdings PTHL|LYRA - Net earnings per share for the last 12 months|Impact BioMedical Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters TNF Pharmaceuticals TNFA|YCBD (cbdmd.com) - Net earnings per share for the last 12 months|PRFX: Earnings per share for the last four quarters|CYTO (Altamira Therapeutics Ltd) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Lipella Pharmaceuticals Inc LIPO|Net earnings per share (EPS TTM) OPTN|Pieris Pharma - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) PROC (Procaps Group S.A.)|Net earnings per share (EPS TTM) petrospharma.com PTPI|QLI - Earnings per share for the last twelve months|Earnings per one share for the last 12 months SLRN|TFF Pharma (TFFP) - Earnings per share for the last twelve months